RAC supplies reference standards for 3 Droxidopa impurities, including Droxidopa Impurity 17 and Droxidopa Impurity 2. Every lot is released with a certificate stating HPLC purity, MS and 1H NMR data, produced under ISO 17034:2016 (ANAB, AR-2832). All items are scheduled on synthesis, typically 3-4 weeks. Pharmacopoeial items follow the monograph numbering (EP, USP, BP); non-pharmacopoeial items are characterised against the drawn structure, and can be re-qualified against your own method on request.
| Padrão | CAS | Status | |
|---|---|---|---|
| Droxidopa Impurity 17 | 96561-34-1 | EM SÍNTESE | |
| Droxidopa Impurity 2 | 5707-55-1 | EM SÍNTESE | |
| Droxidopa Impurity 7 | 29025-01-2 | EM SÍNTESE |
Prices are quoted per enquiry — pack size, documentation and shipping are confirmed together.
Metabolites, NDSRI nitrosamines and degradation products of Droxidopa that no catalogue lists — typically 3–4 weeks from 10 mg to gram scale, released with the same certificate.